“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019

  • He
  • En
  • Home
  • The Firm
  • Practice Areas
  • Attorneys
  • News & Publications
  • Contact
  • He
  • En

Paz Abercohen, Yuval Horn and Yonatan Levinstein of Horn & Co. represented Raziel Therapeutics in its $22 million series C round, led by Pontifax, with participation from existing investors as well as new investors, Catalyst Fund, Quark venture, Peregrine Investments and Wille AG.